These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21120701)

  • 21. Renal denervation for the treatment of resistant hypertension: review and clinical perspective.
    Iliescu R; Lohmeier TE; Tudorancea I; Laffin L; Bakris GL
    Am J Physiol Renal Physiol; 2015 Oct; 309(7):F583-94. PubMed ID: 26224718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.
    Esler MD; Krum H; Schlaich M; Schmieder RE; Böhm M; Sobotka PA;
    Circulation; 2012 Dec; 126(25):2976-82. PubMed ID: 23248063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
    Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up after radio-frequency catheter-based denervation in patients with resistant hypertension.
    Skowerski M; Roleder T; Bańska-Kisiel K; Pysz P; Ochała A; Wojakowski W; Gąsior Z
    Int J Cardiol; 2016 Jul; 215():472-5. PubMed ID: 27131767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design.
    Böhm M; Townsend RR; Kario K; Kandzari D; Mahfoud F; Weber MA; Schmieder RE; Tsioufis K; Hickey GL; Fahy M; DeBruin V; Brar S; Pocock S
    Clin Res Cardiol; 2020 Mar; 109(3):289-302. PubMed ID: 32034481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive effects of renal denervation in spontaneously hypertensive rat based on ultrasonic contrast imaging.
    Li K; Tian J; Zhang Y; Xue Q; Lu C
    Comput Med Imaging Graph; 2017 Jun; 58():56-61. PubMed ID: 28314642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal sympathetic denervation in the treatment of resistant hypertension.
    Sánchez-Álvarez C; González-Vélez M; Stilp E; Ward C; Mena-Hurtado C
    Yale J Biol Med; 2014 Dec; 87(4):527-35. PubMed ID: 25506285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal denervation in the treatment of hypertension].
    Tikkanen I; Lappalainen K
    Duodecim; 2013; 129(8):825-32. PubMed ID: 23720950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal denervation: a new therapeutic approach for resistant hypertension.
    Cao L; Fu Q; Wang B; Li Z
    Chin Med J (Engl); 2014; 127(18):3302-8. PubMed ID: 25266531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension.
    Damascelli B; Patelli G; Tichá V; Della Rocca F; Lattuada S; Sala C; Albertoni A; D'Alessio A; Funaro A; Scotti L
    J Vasc Interv Radiol; 2013 May; 24(5):632-9. PubMed ID: 23622036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.
    Steinberg JS; Shabanov V; Ponomarev D; Losik D; Ivanickiy E; Kropotkin E; Polyakov K; Ptaszynski P; Keweloh B; Yao CJ; Pokushalov EA; Romanov AB
    JAMA; 2020 Jan; 323(3):248-255. PubMed ID: 31961420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catheter-based treatment of drug-resistant hypertension].
    De Benedetti E
    Rev Med Suisse; 2011 Nov; 7(317):2242-4. PubMed ID: 22400353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral catheter-based renal sympathetic denervation in resistant arterial hypertension shows no blood pressure-lowering effect.
    Václavík J; Táborský M; Richter D
    Clin Exp Hypertens; 2013; 35(3):192-4. PubMed ID: 22891761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.